| dc.contributor.author | Raftis, Emma J | |
| dc.contributor.author | Delday, Margaret I | |
| dc.contributor.author | Cowie, Philip | |
| dc.contributor.author | McCluskey, Seánín M | |
| dc.contributor.author | Singh, Mark D | |
| dc.contributor.author | Ettorre, Anna | |
| dc.contributor.author | Mulder, Imke E | |
| dc.date.accessioned | 2018-08-30T13:59:09Z | |
| dc.date.available | 2018-08-30T13:59:09Z | |
| dc.date.issued | 2018-08-13 | |
| dc.identifier.citation | Raftis , E J , Delday , M I , Cowie , P , McCluskey , S M , Singh , M D , Ettorre , A & Mulder , I E 2018 , ' Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration ' , Scientific Reports , vol. 8 , 12024 . https://doi.org/10.1038/s41598-018-30448-z | en |
| dc.identifier.issn | 2045-2322 | |
| dc.identifier.other | PURE: 131620613 | |
| dc.identifier.other | PURE UUID: d72d9b19-867f-463d-811a-a6cb914bb59f | |
| dc.identifier.other | PubMed: 30104645 | |
| dc.identifier.other | PubMedCentral: PMC6089914 | |
| dc.identifier.other | Scopus: 85051652905 | |
| dc.identifier.uri | http://hdl.handle.net/2164/11016 | |
| dc.description | All authors were employees of (or in the case of MID, seconded full-time to) 4D Pharma Research Ltd while engaged in the research project. This work was supported by funding provided by 4D Pharma PLC. 4D Pharma Research Ltd owns a family of patent applications which are pending internationally which are derived from International Patent Publication No. WO2016/203223 which protect the treatment of severe asthma using MRx0004. George Grant, Angela Patterson, Imke Mulder, Seanin McCluskey and Emma Raftis are named as inventors for this patent family. The authors declare no other competing interests. | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Scientific Reports | en |
| dc.rights | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Journal Article | en |
| dc.subject | R Medicine | en |
| dc.subject.lcc | R | en |
| dc.title | Bifidobacterium breve MRx0004 protects against airway inflammation in a severe asthma model by suppressing both neutrophil and eosinophil lung infiltration | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
| dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1038/s41598-018-30448-z | |
| dc.identifier.vol | 8 | en |
